Inventor · disambiguated record
Michael Laflamme
Also filed as: LAFLAMME MICHAEL · LAFLAMME MICHAEL A · LAFLAMME MICHAEL ALAN
6 granted patents·3 pending applications·57 citations·filing 2004–2019
80Inventor score
Top patents by PatentIndex Score
9 records- 0193US7875451B2Formulation to improve survival of transplanted cellsUNIV WASHINGTON·Filed 2006·Granted Jan 25, 2011·25 cites·18 claims
- 0288US8815593B2Induction of human embryonic stem cell derived cardiac pacemaker or chamber-type cardiomyocytes by manipulation of neuregulin signalingUNIV WASHINGTON·Filed 2013·Granted Aug 26, 2014·5 cites·18 claims
- 0387US9994812B2Systems and method for engineering muscle tissueUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2013·Granted Jun 12, 2018·21 cites·14 claims
- 0474US9868937B2Cell and gene based methods to improve cardiac functionREGNIER MICHAEL·Filed 2012·Granted Jan 16, 2018·6 cites·18 claims
- 0564US8603817B2Induction of human embryonic stem cell derived cardiac pacemaker or chamber-type cardiomyocytes by manipulation of neuregulin signalingLAFLAMME MICHAEL A·Filed 2009·Granted Dec 10, 2013·0 cites·8 claims
- 0662US2014329311A1Induction of human embryonic stem cell derived cardiac pacemaker or chamber-type cardiomyocytes by manipulation of neuregulin signalingUNIV WASHINGTON·Filed 2014·Application pending·0 cites
- 0750US2016017268A1Device and methods comprising microelectrode arrays for electroconductive cellsUNIV WASHINGTON CT COMMERCIALI·Filed 2014·Application pending·0 cites
- 0846US12460183B2Mature cardiomyocyte compositionsUNIV HEALTH NETWORK·Filed 2019·Granted Nov 4, 2025·0 cites·12 claims
- 0943US2006040389A1Purified compositions of stem cell derived differentiating cellsMURRY CHARLES E·Filed 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →